- over 2.45 crore individuals registered themselves for phase-3
- Several states, forward of phase-3, mentioned they have been working low on shares
- Tamil Nadu has mentioned it is ready for 1.5 crore doses
Hit by a lethal second Covid wave, India launched the third part of the world’s largest vaccine drive as we speak amid an alarming spike in circumstances. The centre has mentioned over 1 crore doses are nonetheless obtainable with states as vaccine scarcity was red-flagged.
Here are your ten factors on this huge story:
Union Health Minister Harsh Vardhan on Friday mentioned over 2.45 crore individuals have registered themselves on Co-Win, the federal government’s registration web site, for the third part.
Delhi, Maharashtra, Tamil Nadu, Madhya Pradesh, Karnataka, Bengal, Kerala, Rajasthan, Jharkhand and Punjab are among the many states that said they’re running low on vaccine stocks forward of Phase 3.
The centre has supplied “more than 16.33 crore Covid vaccine doses to states and union territories for free,” Dr Harsh Vardhan mentioned in a tweet on Friday night, stressing that “more than 1 crore doses are still available in stocks with them”. Of this, “the total consumption including wastages is 15,33,56,503 doses”, an official assertion mentioned.
Delhi Chief Minister Arvind Kejriwal on Friday urged citizens not to queue up for Covid shots. “Don’t queue up for vaccines tomorrow. As soon as vaccines arrive, we will let you know,” Mr Kejriwal mentioned. Delhi is about to obtain round 3 lakh Covishield doses by Sunday, he added. “Both vaccine makers (Serum Institute and Bharat Biotech) will give us 67 lakh doses each over next two months,” Mr Kejriwal mentioned.
In Mumbai, vaccination for the age group 18-44 will be done at five centres today – Nair Hospital, BKC Jumbo Facility, Cooper Hospital, Seven Hills Hospital and Rajawadi Hospital. At least 20,000 doses of vaccines can be found for the age group, a civic physique official mentioned.
Tamil Nadu has mentioned it is ready for 1.5 crore doses ordered from Bharat Biotech and Serum Institute. Bengal too is working low on vaccines and will not have the ability to kick off vaccine drive from as we speak for these between 18-44 years, a senior well being division official informed information company PTI on Friday. Telangana too has mentioned it is working low on vaccine shares.
For the newest part of the inoculation drive that began in January, the centre has tweaked the vaccine coverage to permit states and personal entities to purchase doses straight from vaccine makers. Manufacturers are free to produce 50 per cent of the doses to states and within the open market. The change in coverage, nonetheless, has introduced the federal government beneath criticism.
The Supreme Court on Friday questioned the federal government over different prices of vaccines for the states and centre. (*10*) the highest courtroom requested, and informed the centre that India should observe the “national immunisation model which we had followed since Independence”.
Last week, the federal government mentioned its procurement worth for each vaccines – Bharat Biotech’s Covaxin and the Serum Institute’s Covishield – would stay at Rs 150 per dose, and that the vaccines it procures shall be free for states. Amid the controversy, Bharat Biotech has lowered the worth for states from Rs 600 to Rs 400 per dose whereas the SII has lower the costs from Rs 400 to Rs 300.
India has been witnessing an alarming surge in Covid circumstances over the previous couple of weeks. Experts consider growing the vaccine protection will improve the nation’s struggle towards Covid. Over 15 crore doses have been administered because the vaccines have been first rolled out in January, as per official knowledge.
#Centre #States #Vaccine #Stocks #RollOut #Begins #Points